China Medical & Healthcare Group Limited Provided Group Earnings Guidance for Year Ended 31 December 2021. The Group is expected to record an increase in loss attributable to shareholders of the Company for the year ended 31 December 2021 in the range of approximately HKD 130 million to HKD 190 million (subject to any further impairment or other adjustments) as compared with a loss of approximately HKD 111.9 million in 2020. This was mainly due to the increase in impairment loss under expected credit loss model of financial assets; a provision for properties held for sale; and an impairment loss recognized on goodwill, which were partially off-set by the decreased losses on fair value of investments held for trading and investment properties.